down arrow

CYBERDYNE, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3311530004
JPY
190.00
-1 (-0.52%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

147.00223.00
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Poor long term growth as Operating profit has grown by an annual rate -10.10% of over the last 5 years

 
3

Risky - Negative EBITDA

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 27,214 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

-1.13%

stock-summary
Price to Book

0.68

Revenue and Profits:
Net Sales:
1,000 Million
(Quarterly Results - Jun 2025)
Net Profit:
248 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.04%
0%
-1.04%
6 Months
9.83%
0%
9.83%
1 Year
11.11%
0%
11.11%
2 Years
-12.04%
0%
-12.04%
3 Years
-40.25%
0%
-40.25%
4 Years
-46.78%
0%
-46.78%
5 Years
-75.45%
0%
-75.45%

CYBERDYNE, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

CYBERDYNE, Inc. Reports Strong Financial Performance in Latest Quarter

CYBERDYNE, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported a positive financial performance for the quarter ending June 2025. The company has demonstrated significant improvements across various financial metrics, indicating a robust operational capacity.

One of the standout achievements for CYBERDYNE, Inc. is its operating cash flow, which reached its highest level at JPY -60 MM. This marks a notable milestone for the company, reflecting improved cash management and operational efficiency.

Additionally, the company has successfully reduced its raw material costs by 26.49% year-over-year, contributing to enhanced profitability. This reduction in costs is expected to bolster the company's margins and overall financial health.

In terms of profitability, CYBERDYNE, Inc. reported its highest operat...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.59%
EBIT Growth (5y)
-10.10%
EBIT to Interest (avg)
-113.14
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.10
Tax Ratio
20.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.62
EV to EBIT
-10.96
EV to EBITDA
-17.16
EV to Capital Employed
0.55
EV to Sales
4.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.98%
ROE (Latest)
-1.78%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -13.42% vs 10.53% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 3,200.00% vs -102.81% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,000.00",
          "val2": "1,155.00",
          "chgp": "-13.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-52.00",
          "val2": "-131.00",
          "chgp": "60.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "4.00",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "248.00",
          "val2": "-8.00",
          "chgp": "3,200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-204.00%",
          "val2": "-246.80%",
          "chgp": "4.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.69% vs 32.38% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 57.16% vs -319.34% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,384.00",
          "val2": "4,354.00",
          "chgp": "0.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-904.00",
          "val2": "-1,059.00",
          "chgp": "14.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "303.00",
          "val2": "482.00",
          "chgp": "-37.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "314.00",
          "val2": "-297.00",
          "chgp": "205.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-706.00",
          "val2": "-1,648.00",
          "chgp": "57.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-341.20%",
          "val2": "-398.70%",
          "chgp": "5.75%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
1,000.00
1,155.00
-13.42%
Operating Profit (PBDIT) excl Other Income
-52.00
-131.00
60.31%
Interest
0.00
4.00
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
248.00
-8.00
3,200.00%
Operating Profit Margin (Excl OI)
-204.00%
-246.80%
4.28%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -13.42% vs 10.53% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 3,200.00% vs -102.81% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
4,384.00
4,354.00
0.69%
Operating Profit (PBDIT) excl Other Income
-904.00
-1,059.00
14.64%
Interest
303.00
482.00
-37.14%
Exceptional Items
314.00
-297.00
205.72%
Consolidate Net Profit
-706.00
-1,648.00
57.16%
Operating Profit Margin (Excl OI)
-341.20%
-398.70%
5.75%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 0.69% vs 32.38% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 57.16% vs -319.34% in Mar 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About CYBERDYNE, Inc. stock-summary
stock-summary
CYBERDYNE, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."